When Michelle Gidion first noticed the blue bruises dotted across her lower legs, she put them down to the family dog bashing ...

Several measures can be adopted to avoid and combat the flu. However, it is important to note that viruses, like influenza, frequently change its structure to evade the immune system, resulting in new ...

A study by former Junior Associate Professor Kazuo Takayama, currently a professor of the Institute of Science Tokyo, ...

The seasonal timing of when infants receive the new respiratory syncytial virus (RSV) immunization is crucial for ensuring ...

Protection against RSV among infants and birthing parents differed by race and ethnicity, indicating the need to ensure equitable access to RSV products.

Pfizer's Abrysvo and GSK's Arexvy both received FDA-approval b in 2024 to include immunization of adults aged 50 to 59 years at increased risk for RSV disease.

Key treatments for Alzheimer’s, rare cancers, and infectious diseases are under review, with new vaccines and therapies like ...

Cha Seung-won was selected as a model for the Respiratory Synthetic Virus (RSV) vaccine 'AlexB'. GSK Korea announced that it ...

A phase 3 trial involving nearly 25,000 older adults across 17 countries found that a single dose of the RSVPreF3 OA vaccine ...

Some assume pneumonia is an inevitable consequence of ageing, while others may not realise they are at risk, says infectious ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

The Allan Labor Government is backing a new study to boost the number of expectant mothers having the Respiratory Syncytial Virus (RSV) immunisation ...